Potassium clavulanate is frequently combined with semisynthetic penicillins to treat community-acquired infections caused by Escherichia coli, Proteus spp., Enterobacter cloacae, Haemophilus influenzae, Streptococcus pneumoniae, and other pathogens.
GMP、DMF
